Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon.

J Hand Surg Am · Sep 16 2020 · Review

Gallegos JE, Inglesby DC, Young ZT, Herrera FA

College of Medicine, Medical University of South Carolina, Charleston, SC

Hand & Upper Extremity

SUMMARY — THE REDUCTIONReviews evidence supporting botulinum toxin injection as an effective option for Raynaud phenomenon refractory to standard medical therapy.
Abstract, as published

Raynaud phenomenon (RP) is a condition causing vasospasm in the fingers and toes of patients that can have a significant negative impact on quality of life. This can lead to pain, ulceration, and possible loss of digits. Several pharmacological options are available for treatment. However, RP can often be refractory to traditional modalities, leaving surgery or injections as the next available options. This article provides a review and update on the use of botulinum toxin as an effective therapy for the treatment of RP refractory to medical management.

Featured in the 2026-09-19 issue.

← Tumors of the Hand and the Wrist.Ultrasound Diagnosis of Upper Extremity Peripheral Entrapment… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.